Ahmad Alenezi: Harrison.ai Secured Its 13th FDA Clearance, And This One Is a Literal Life-Saver
Ahmad Alenezi, Nuclear Medicine Technology Specialist, Assistant Professor at Kuwait University, shared on LinkedIn:
”Big news for the stroke care community!
Harrison.ai just secured its 13th FDA clearance, and this one is a literal life-saver.
They have developed the first AI cleared to triage acute ischemic stroke (tissue injury) on a patient’s very first non-contrast CT scan.
Why this matters?:
In stroke care, ‘time is brain.’
Traditionally, AI needed a second, more complex scan (CTA) to flag a blockage.
By catching signs of injury on the initial ER scan, we’re cutting down the ‘door-to-needle’ time when every second counts toward a patient’s recovery.
This isn’t just about faster tech, it’s about getting clinicians the right data earlier to prevent permanent disability.
Huge win for the team and a massive step forward for emergency radiology.
Those milestones and developments necessitate the integration of AI medical education in our syllabus.”
Stay updated with Hemostasis Today.
-
May 23, 2026, 01:51Paula Greter: Access and Innovation in Hemophilia through ERAH2026
-
May 22, 2026, 17:30Veronica Sanchez: Do You Live with Pain after a Stroke?
-
May 22, 2026, 17:25Maxime Dely: A Simple but Powerful Indicator of Platelet Quality
-
May 22, 2026, 17:24Jim Hoffman: A New Approach to Balancing Host Defense and Tissue Protection
-
May 22, 2026, 17:22Lucia Rugeri: Advancing Multidisciplinary Care for Heavy Menstrual Bleeding in Women with Bleeding Disorders
-
May 22, 2026, 17:20Nour Al-Mozain: Optimizing PBSC Collection Through Real-Time CD34+ Monitoring
-
May 22, 2026, 16:30Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
-
May 22, 2026, 16:29Danny Hsu: The Reversal Dilemma – Rethinking our approach to DOAC-associated ICH
-
May 22, 2026, 16:28Bartosz Hudzik: High Bleeding Risk Does Not Always Mean Bleeding-Risk Predominance